kvmsex.blogg.se

These annual filings show that for 17 of the 20 top-selling drugs worldwide in 2020, revenue to pharmaceutical companies from U.S. (For detailed footnotes that describe our methodology in further, download the full PDF version of this report.) Where revenue from licensing marketing or sales of a drug to another company are reported, that revenue is not included. dollar equivalent using the exchange rate of the date of the report. Revenue reported in sources in currencies other than U.S. Securities and Exchange Commission or, for companies based outside of the U.S., analogous annual reports. sales revenue to global sales revenue as reported by the companies in annual filings with the U.S. In this analysis, we attempted to quantify the spending disparity by analyzing the sources of revenue for the 20 top-selling drugs globally in 2020.įor all 20 drugs, we compared U.S. spends more per capita for prescription drugs than any other industrialized nation. Earlier studies have identified that the U.S. sales revenue more than triple the rest of the world.Īmericans spend far too much on prescription drugs. Eli Lily’s type 2 diabetes drug Trulicity, Roche’s multiple sclerosis drug Ocrevus and Amgen and Pfizer’s autoimmune disease drug Enbrel, all three of which had U.S.sales revenue four times greater than the rest of the world and AbbVie’s autoimmune disease drug Humira, which had U.S.sales revenue five times greater than the rest of the world Gilead Sciences’ HIV medication Biktarvy, which had U.S.Drugs with significant sales revenue disparities between the U.S.11 of the 13 pharmaceutical companies selling these top drugs made more money in the United States from these drugs than they did in the rest of the world combined.sales revenue was double revenue to the sales of the rest of the world or more. For 11 of the 20 top-selling drugs worldwide, U.S.sales than from sales to all other countries in the rest of the world combined. For 17 of the 20 top-selling drugs worldwide in 2020, pharmaceutical corporations made more money from U.S.spent almost double what the rest of the world combined did on these top 20 drugs. sales of the 20 top-selling drugs worldwide totaled $101.1 billion while sales to the rest of the world totaled nearly $57 billion.